ASP Isotopes Inc.
Company Stats
- Market Cap
- $406.3M
- as of Sep 30, 2026
- Shares Outstanding
- 153.3M
- Free Float
- 77.0%
Income Statement
- Revenue
- $23.8M
- Operating Income
- -$59.9M
- Net Income
- -$159.8M
- EBITDA
- -$58.0M
- FCF Margin, 3Y Avg
- -874.5%
- FCF Margin, Worst Year
- -1788.3%
Cash Flow
- Free Cash Flow
- -$47.4M
- FCF Yield
- -11.7%
- Owner FCF Yield
- -15.6%
Balance Sheet
- Cash & Equivalents
- $285.6M
Returns & Capital
- SBC, 3Y Avg
- $11.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $23.8M | -$47.4M | -198.9% |
| FY2024 | $4.1M | -$26.4M | -636.4% |
| FY2023 | $433,026 | -$7.7M | -1788.3% |
| FY2022 | $0 | -$7.4M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 15, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Coverage
October 15, 2026
Deals
ASP Isotopes Unit Locks Joint Venture With Necsa
August 14, 2026
Industry Earnings Roundup
Materials & Chemicals: Demand and Pricing Firm, Costs Squeeze
July 16, 2026
Deals
ASP Isotopes to Acquire Quantum Leap Energy Notes in $109.2 Million Deal
July 2, 2026
Small-Cap Signal
AI Infrastructure Capital Floods In While Biotech Trials Split
ASP Isotopes Unit Locks Joint Venture With Necsa
August 14, 2026
Industry Earnings Roundup
Materials & Chemicals: Demand and Pricing Firm, Costs Squeeze
July 16, 2026
Deals
ASP Isotopes to Acquire Quantum Leap Energy Notes in $109.2 Million Deal
July 2, 2026
Small-Cap Signal
AI Infrastructure Capital Floods In While Biotech Trials Split